Prognostic factors of esophageal cancer

Yuukou Kitagawa, M. Ueda, N. Ando, S. Ozawa, H. Takeuchi, M. Kitajima

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

A number of molecules involved in the process of invasion and metastasis of cancer cells have been demonstrated as a biological prognostic parameter. In esophageal cancer, overexpression of the oncogenes (c-erbB, int-2/hst-1/cyclin D1, MDM2), altered expression of suppressor genes (p 16, DCC), and abnormal expression of adhesion molecules (E-cadherin, alpha-catenin) has been reported as markers of high malignant potential. Proliferation markers (Ki-67, AgNORs, PCNA) and angiogenetic factors (intratumoral microvessel density, VEGF) are also related to the prognosis of the patients with various cancers including esophageal cancer. Prognostic significance of p53 is still controversial. In addition to the clinicopathological parameters, combination of these biological markers would be important to predict the clinical outcome of the cases and to establish an individualized strategy of the treatment of each case according to the biological behavior of the cancer cells.

Original languageEnglish
Pages (from-to)2011-2020
Number of pages10
JournalGan to kagaku ryoho. Cancer & chemotherapy
Volume25
Issue number13
Publication statusPublished - 1998 Nov

Fingerprint

Esophageal Neoplasms
alpha Catenin
Suppressor Genes
Neoplasms
Cyclin D1
Proliferating Cell Nuclear Antigen
Cadherins
Microvessels
Oncogenes
Vascular Endothelial Growth Factor A
Biomarkers
Neoplasm Metastasis
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Pharmacology

Cite this

Kitagawa, Y., Ueda, M., Ando, N., Ozawa, S., Takeuchi, H., & Kitajima, M. (1998). Prognostic factors of esophageal cancer. Gan to kagaku ryoho. Cancer & chemotherapy, 25(13), 2011-2020.

Prognostic factors of esophageal cancer. / Kitagawa, Yuukou; Ueda, M.; Ando, N.; Ozawa, S.; Takeuchi, H.; Kitajima, M.

In: Gan to kagaku ryoho. Cancer & chemotherapy, Vol. 25, No. 13, 11.1998, p. 2011-2020.

Research output: Contribution to journalArticle

Kitagawa, Y, Ueda, M, Ando, N, Ozawa, S, Takeuchi, H & Kitajima, M 1998, 'Prognostic factors of esophageal cancer', Gan to kagaku ryoho. Cancer & chemotherapy, vol. 25, no. 13, pp. 2011-2020.
Kitagawa Y, Ueda M, Ando N, Ozawa S, Takeuchi H, Kitajima M. Prognostic factors of esophageal cancer. Gan to kagaku ryoho. Cancer & chemotherapy. 1998 Nov;25(13):2011-2020.
Kitagawa, Yuukou ; Ueda, M. ; Ando, N. ; Ozawa, S. ; Takeuchi, H. ; Kitajima, M. / Prognostic factors of esophageal cancer. In: Gan to kagaku ryoho. Cancer & chemotherapy. 1998 ; Vol. 25, No. 13. pp. 2011-2020.
@article{92dcda80cb3c402fa35ab2b5c293f079,
title = "Prognostic factors of esophageal cancer",
abstract = "A number of molecules involved in the process of invasion and metastasis of cancer cells have been demonstrated as a biological prognostic parameter. In esophageal cancer, overexpression of the oncogenes (c-erbB, int-2/hst-1/cyclin D1, MDM2), altered expression of suppressor genes (p 16, DCC), and abnormal expression of adhesion molecules (E-cadherin, alpha-catenin) has been reported as markers of high malignant potential. Proliferation markers (Ki-67, AgNORs, PCNA) and angiogenetic factors (intratumoral microvessel density, VEGF) are also related to the prognosis of the patients with various cancers including esophageal cancer. Prognostic significance of p53 is still controversial. In addition to the clinicopathological parameters, combination of these biological markers would be important to predict the clinical outcome of the cases and to establish an individualized strategy of the treatment of each case according to the biological behavior of the cancer cells.",
author = "Yuukou Kitagawa and M. Ueda and N. Ando and S. Ozawa and H. Takeuchi and M. Kitajima",
year = "1998",
month = "11",
language = "English",
volume = "25",
pages = "2011--2020",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "13",

}

TY - JOUR

T1 - Prognostic factors of esophageal cancer

AU - Kitagawa, Yuukou

AU - Ueda, M.

AU - Ando, N.

AU - Ozawa, S.

AU - Takeuchi, H.

AU - Kitajima, M.

PY - 1998/11

Y1 - 1998/11

N2 - A number of molecules involved in the process of invasion and metastasis of cancer cells have been demonstrated as a biological prognostic parameter. In esophageal cancer, overexpression of the oncogenes (c-erbB, int-2/hst-1/cyclin D1, MDM2), altered expression of suppressor genes (p 16, DCC), and abnormal expression of adhesion molecules (E-cadherin, alpha-catenin) has been reported as markers of high malignant potential. Proliferation markers (Ki-67, AgNORs, PCNA) and angiogenetic factors (intratumoral microvessel density, VEGF) are also related to the prognosis of the patients with various cancers including esophageal cancer. Prognostic significance of p53 is still controversial. In addition to the clinicopathological parameters, combination of these biological markers would be important to predict the clinical outcome of the cases and to establish an individualized strategy of the treatment of each case according to the biological behavior of the cancer cells.

AB - A number of molecules involved in the process of invasion and metastasis of cancer cells have been demonstrated as a biological prognostic parameter. In esophageal cancer, overexpression of the oncogenes (c-erbB, int-2/hst-1/cyclin D1, MDM2), altered expression of suppressor genes (p 16, DCC), and abnormal expression of adhesion molecules (E-cadherin, alpha-catenin) has been reported as markers of high malignant potential. Proliferation markers (Ki-67, AgNORs, PCNA) and angiogenetic factors (intratumoral microvessel density, VEGF) are also related to the prognosis of the patients with various cancers including esophageal cancer. Prognostic significance of p53 is still controversial. In addition to the clinicopathological parameters, combination of these biological markers would be important to predict the clinical outcome of the cases and to establish an individualized strategy of the treatment of each case according to the biological behavior of the cancer cells.

UR - http://www.scopus.com/inward/record.url?scp=0032214598&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032214598&partnerID=8YFLogxK

M3 - Article

C2 - 9838901

AN - SCOPUS:0032214598

VL - 25

SP - 2011

EP - 2020

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 13

ER -